This assertion is supported again by our observations of Ang II infusion in mice with a deletion in the gene for ACE2 [46] and by our experimental findings of ACE2 treatment in murine Alport syndrome [10, 27]. The gene discussed is ACE2; the disease is Alport syndrome.